PhaseRx, Inc. Cm St Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch PZRXQ and buy or sell other stocks, ETFs, and their options commission-free!

About PZRXQ

PhaseRx, Inc. operates as a bio pharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. Its product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency, argininosuccinate lyase deficiency and argininosuccinate synthetase deficiency. 

CEO
Robert W. Overell, PhD
CEORobert W. Overell, PhD
Employees
21
Employees21
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2006
Founded2006
Employees
21
Employees21

PZRXQ Key Statistics

Market cap
1.17K
Market cap1.17K
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
1.15K
Average volume1.15K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.0001
52 Week high$0.0001
52 Week low
$0.00
52 Week low$0.00
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.